The clinical study on short term continuous subcutaneous insulin infusion combination of sitagliptin and metformin as therapy on newly diagnosed type2 diabetes

Trial Profile

The clinical study on short term continuous subcutaneous insulin infusion combination of sitagliptin and metformin as therapy on newly diagnosed type2 diabetes

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Insulin (Primary) ; Metformin (Primary) ; Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 03 Jun 2016 Status changed from not yet recruiting to completed.
    • 30 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top